Abiramasundari G, Gowda C M Mohan, Pampapathi G, Praveen Sheela, Shivamurugan S, Vijaykumar M, Devi A, Sreepriya M
Department of Microbiology and Biotechnology, Bangalore University, Jnana Bharathi Campus, Bangalore, 560 056, Karnataka, India.
Pampapathi Veterinary Centre & Diagnostics, J.P Nagar 1st Phase, Bangalore, 560 078 Karnataka, India.
Biomed Pharmacother. 2017 Mar;87:342-354. doi: 10.1016/j.biopha.2016.12.094. Epub 2017 Jan 5.
Indian ethnomedicine acclaims the use of Tinospora cordifolia (TC) in the treatment of bone fractures and vat rakta (gout). The objective of the study is to investigate the effects of alcoholic extract of Tinospora cordifolia on bone remodeling (involving osteoblastic and osteoclastic actions) in vitro and protect against ovariectomy-induced bone loss in vivo. Human osteoblast-like cells MG-63 and primary osteoblast cells isolated from rat femur were used as osteoblast models and RAW macrophage cell line 264.7 induced to take up osteoclastic lineage using RANK ligand were used as osteoclast models in the current study. Sirius red staining, quantification of osteocalcin, cytopathological analysis by Hematoxylin/eosin staining and semiquantitative reverse transcription PCR (RT-PCR) was carried out to ascertain the effects of T. cordifolia extract on osteoblast cells. MTT assay was perfomed to understand the influence of T. cordifolia extract on osteoclast cells. Adult female Sprague-Dawley rats were used as in vivo models to study the effect of T. cordifolia on ovariectomy induced bone loss. Radiological (DEXA analysis), Biochemical (markers of bone formation and resorption), histopathological (Hematoxylin/eosin staining) and histomorphometric analysis of the bone was carried out. Treatment with T. cordifolia extract resulted in enhanced collagen deposition, increased levels of osteocalcin, increased expression of osteogenic genes all indicative of favourable osteoblastogenesis. Treatment with T. cordifolia extract did not exert any significant influence on the proliferation of osteoclasts. Pretreatment with T. cordifolia extract at a dose of 50mg/kg body wt/day orally for 21days followed by treatment for 12 weeks post ovariectomy was able to prevent ovariectomy-induced bone loss in vivo. Results of the study support the use of T. cordifolia in Indian ethnomedicine for the treatment of bone diseases and fractures.
印度民族医学推崇使用心叶锡生藤(TC)治疗骨折和痛风。本研究的目的是调查心叶锡生藤醇提取物在体外对骨重塑(涉及成骨细胞和破骨细胞作用)的影响,并在体内预防去卵巢诱导的骨质流失。在本研究中,将人成骨样细胞MG-63和从大鼠股骨分离的原代成骨细胞用作成骨细胞模型,将用RANK配体诱导分化为破骨细胞谱系的RAW巨噬细胞系264.7用作破骨细胞模型。进行天狼星红染色、骨钙素定量、苏木精/伊红染色的细胞病理学分析和半定量逆转录PCR(RT-PCR),以确定心叶锡生藤提取物对成骨细胞的影响。进行MTT试验以了解心叶锡生藤提取物对破骨细胞的影响。成年雌性Sprague-Dawley大鼠用作体内模型,以研究心叶锡生藤对去卵巢诱导的骨质流失的影响。对骨进行放射学(双能X线吸收法分析)、生化(骨形成和吸收标志物)、组织病理学(苏木精/伊红染色)和组织形态计量学分析。心叶锡生藤提取物处理导致胶原蛋白沉积增加、骨钙素水平升高、成骨基因表达增加,所有这些都表明成骨作用良好。心叶锡生藤提取物处理对破骨细胞增殖没有显著影响。以50mg/kg体重/天的剂量口服心叶锡生藤提取物预处理21天,然后在去卵巢后治疗12周,能够在体内预防去卵巢诱导的骨质流失。研究结果支持印度民族医学中使用心叶锡生藤治疗骨疾病和骨折。